A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (AT3 RNA-Seq)
Investigation and validation of genes that regulate CXCL9 expression by RNA sequencing Overall design: AT-3 cells were stimulated with IFNg/TNF for 8 or 14 hours.